Company profile
Avanos Medical, Inc.
NYSE: AVNS · Healthcare · Medical - Devices
#188 of 1,422 Healthcare companies by revenue45th-percentile growth
EA Score
73BFH 72DQ 84GM 54SS 75
v0.1 · 65/100 weight · provisional
↑ filing timeliness, workforce scale · ↓ 3-yr revenue growth, revenue growth (YoY)
Methodology →Revenue TTM
$715.9M
Rev growth YoY (TTM)
+3.9%
Net income (FY)
-$72.9M
Employees
2,287
as of 2026-08-10
Market cap
$1.2B
as of 2026-08-10
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$701.2M$701.2M2025
Net income-$72.9M-$72.9M2025
Operating income-$61.6M-$61.6M2025
Total assets$1.1B$1.1B2025
Liabilities$295.5M$295.5M2025
Equity$778.2M$778.2M2025
Revenue trend
FY2018 – FY2025 · USD
FY18
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
Filed disclosures · FY2025
By product
Corporate Other100%
By geography
UNITED STATES100%
The read
What is Avanos Medical, Inc.’s revenue?
Avanos Medical, Inc. booked $701.2M in FY2025 revenue, growing 1.9% year over year — about the middle of the pack among Healthcare companies we track, at a -10.4% net margin.
Peers · Healthcare
Amphastar Pharmaceuticals, Inc.77B+Supernus Pharmaceuticals, Inc.76B+Sienna Senior Living Inc.75B+Ultragenyx Pharmaceutical Inc.58CCresco Labs Inc.37DDoximity, Inc.73BNeighbors
Fulton →Key facts
CEODavid C. Pacitti
SectorHealthcare
IndustryMedical - Devices
HeadquartersAlpharetta, GA
ExchangeNYSE: AVNS
Employees2,287
IPO date2014-10-21
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.